CompoAtlas

Clear Micronised Creatine (Opticreatine™) - Passion-Hibiscus

Food supplement declared in France, decision dated 14 February 2026

Clear Micronised Creatine (Opticreatine™) - Passion-Hibiscus (NLAB) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Créatine monohydrate. None of the rules we check flags an issue with its declared composition.

Brand
NLAB
Food business operator placing the product on the market
SUPPLEMENTS DISTRIBUTION SRL
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Powder
Daily dose
3 g
Directions for use
Mélanger 3 g (environ 5 doseurs) par jour, répartis sur les repas, et/ou immédiatement après l’effort dans 200 mL d'eau.
Intended populations
Men and women aged 18 and over, People over 60, Men, Women
Not recommended (according to the manufacturer)
Autre : Force musculaire, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Nourrissons (moins de 1 an), Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Autre : Force musculaire, Sport
Flavourings
Passion-Hibiscus

Declaration 356989, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Créatine monohydratenot declared

Additives

E330, E960

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Ne pas dépasser la portion journalière recommandée. À conserver au sec, à l’abri de la chaleur et de la lumière. Garder hors de portée des jeunes enfants. Produit fabriqué dans une usine certifiée selon la norme NF EN 17444 garantissant des contrôles renforcés contre le risque de contamination par des substances interdites. Produit fabriqué dans un atelier utilisant des allergènes (lait, œufs, céréales, soja, poisson, mollusques et crustacés).

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Créatine monohydrate
    Read the warning, when it applies and the studies cited

    Creatine Monohydrate

    Route of administration: Oral

    Cautions and warnings

    When using this product you may gain weight (Volek and Rawson 2004; Bemben et al. 2001; Mihic et al. 2000).

    Sources cited by Health Canada (3)
    • Bemben MG, Bemben DA, Loftiss DD, Knehans AW. 2001. Creatine supplementation during resistance training in college football athletes. Medicine & Science in Sports & Exercise 33(10):1667-1673.
    • Mihic S, MacDonald JR, McKenzie S, Tarnopolsky MA. 2000. Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women. Medicine & Science in Sports and Exercise 32(2):291-296.
    • Volek JS, Rawson ES. 2004. Scientific basis and practical aspects of creatine supplementation for athletes. Nutrition 20(7-8):609-614.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (Pline and Smith 2005; Pritchard and Kalra 1998).

    Sources cited by Health Canada (2)
    • Pline KA, Smith CL. 2005. The effect of creatine intake on renal function. The Annals of Pharmacotherapy 39(6):1093-1096.
    • Pritchard NR, Kalra PA. 1998. Renal dysfunction accompanying oral creatine supplements. The Lancet 351(9111):1252-1253.

    Health Canada monograph dated 28 June 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : NLAB

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Clear Micronised Creatine (Opticreatine™) - Passion-Hibiscus (NLAB): composition and regulation”, https://compoatlas.com/en/supplements/products/356989-clear-micronised-creatine-opticreatinetm-passion-hibiscus, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line